Prostate Cancer - Results from #140

First Participant Treated at the Highest Dose Level in Clarity’s Theranostic Prostate Cancer Trial August 25, 2023

Superior detection of significant prostate cancer by transperineal prostate biopsy using MRI-transrectal ultrasound fusion image guidance over cognitive registration. August 25, 2023

Is There a Role of Interim PSMA PET in Chemotherapy of Prostate Cancer? August 25, 2023

Quality of Life after Radical Prostatectomy: A Longitudinal Study. August 25, 2023

Prevalence and determinants of decision regret in long-term prostate cancer survivors following radical prostatectomy. August 25, 2023

Androgen receptor binding sites enabling genetic prediction of mortality due to prostate cancer in cancer-free subjects. August 25, 2023

Use of artificial intelligence in the detection of primary prostate cancer in multiparametric MRI with its clinical outcomes: a protocol for a systematic review and meta-analysis. August 24, 2023

Clinical implications of AR alterations in advanced prostate cancer: A multi-institutional collaboration. August 24, 2023

Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER). August 24, 2023

Deep-learning prostate cancer detection and segmentation on biparametric versus multiparametric magnetic resonance imaging: Added value of dynamic contrast-enhanced imaging. August 24, 2023

Frequency of Biopsy and Tumor Grade Before vs After Introduction of Prostate Magnetic Resonance Imaging. August 24, 2023

FDA Grants Priority Review for XTANDI® in Non-Metastatic Castration-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence August 23, 2023

Real-world Outcomes and Predictive Biomarkers for 177Lutetium Prostate-specific Membrane Antigen Ligand Treatment in Metastatic Castration-resistant Prostate Cancer: A European Association of Urology Young Academic Urologists Prostate Cancer Working Group August 23, 2023

Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancer. August 23, 2023

Docetaxel Provides Oncological Benefits in the Era of New-Generation Androgen Receptor Inhibitors - or Is Three a Crowd? August 23, 2023

DIPPER trial protocol: A multi-centre, randomised trial of salvage radiotherapy versus surveillance for biochemical recurrence after radical prostatectomy (ANZUP 2002). August 23, 2023

A territory-wide real-world efficacy and toxicity analysis of abiraterone acetate versus docetaxel in 574 Asian patients with metastatic hormone-sensitive prostate cancer. August 23, 2023

Estimated Absolute Percentage of Biopsied Tissue Positive for Gleason Pattern 4 (eAPP4) in Low Dose Rate Prostate Brachytherapy: Evaluation of Prognostic Utility in a Large Cohort. August 23, 2023

Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial August 22, 2023

Head-to-Head Comparison of 68Ga-NODAGA-JR11 and 68Ga-DOTATATE PET/CT in Patients with Metastatic, Well-Differentiated Neuroendocrine Tumors: Interim Analysis of a Prospective Bicenter Study August 22, 2023

Page 8 of 1332